 |
| Near Patient MolecularSolution |
At or close to when and where the patient is receiving care, point-of-care molecular tests look for specific mutations in a chromosome or gene which may cause or affect the likelihood of acquiring a certain disease or ailment, such as cancer.
Point-of-care diagnosis, also known as Near Patient Molecular Solutions, is a technology that aids in diagnosing and monitoring health at the patient's convenience. The technology of diagnostics is divided into segments based on technological advances PCR, sequencing of genes, hybridization, and microarray, end user hospitals, homecare, and other end users, application infectious diseases, oncology, hematology, prenatal testing, endocrinology, and other application.
Near Patient Molecular Solutions are quick medical examinations that can be done right at the patient's bedside. In many instances, simplicity wasn't attainable until technology advanced, making tests both viable and later able to hide their complexity. Utilizing portable, lightweight, and handheld tools such as a blood glucose meter, a nerve conduction study device, and test kits for CRP, HBA1C, homocysteine, and HIV salivary assay is a common way to perform POCT. While a handheld instrument is not available, small bench analysis tools or fixed equipment can also be used; the objective is to gather the material and collect the results in a very short amount of time at or close to the patient's location so that the treatment plan can be modified as necessary before the patient departs.
By making Near Patient Molecular Solutions techniques cost-effective for numerous conditions, including diabetes, a condition carpal tunnel syndrome, and acute coronary syndrome, more affordable, quicker, and sharper POCT devices have increased their use. During the COVID-19 pandemic, POCT underwent rapid development in an effort to shorten turnaround times and increase usability in comparison to the gold standard lab-based PCR method. These include quick tests for antigens, different techniques for amplifying nucleic acids, and innovative sensors. Tests addressing blood, saliva, urine, and tear have been presented. A variety of tests have been developed, including smartphone-based platforms. Although reliability needs to be improved, saliva in particular may give significantly high detection rates in conjunction with a simple and user-friendly process.